Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 5, 2006, Pages 1308-1316

  Semrau, Robert ^a   Mueller, Rolf Peter ^a   Stuetzer, Hartmut ^a   Staar, Susanne ^b   Schroeder, Ursula ^a   Guntinas Lichius, Orlando ^a   Kocher, Martin ^a   Eich, Hans Theodor ^a   Dietz, Andreas ^c   Flentje, Michael ^d   Rudat, Volker ^e   Volling, Peter ^f   Schroeder, Michael ^g   Eckel, Hans Edmund ^h  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Krankenhaus St Juergens   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f Evangelisches Krankenhaus   (Germany)

^g KLINIKUM KASSEL   (Germany)

^h GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Chemotherapy; Head and neck neoplasms; Hemoglobin level; Radiotherapy

Indexed keywords

HEAD-AND-NECK NEOPLASMS; HEMOGLOBIN LEVEL; OROPHARYNGEAL CARCINOMAS; P-HB LEVELS;

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; HEMOGLOBIN; TUMORS;

RADIOTHERAPY;

CARBOPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMOGLOBIN A; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645344341     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.10.039     Document Type: Article

References (29)

1. L.N. Nguyen, K.K. Ang Radiotherapy for cancer of the head and neck Altered fractionation regimens Lancet Oncol 3 2002 693 701
2. S. Staar, V. Rudat, H. Stuetzer Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 1161 1171
3. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Statist Assoc 53 1958 457 481
4. D.W. Hosmer, S. Lemeshow Applied survival analysis. Regression modelling of time to event data 1999 John Wiley & Sons New York
5. D.R. Cox, D. Oakes Analysis of survival data 1984 Chapman Hall London
6. K.K. Fu, T.F. Pajak, A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
7. J. Bourhis, H. Audry, J. Overgaard Meta-analysis of conventional versus altered fractionated radiotherapy in head-and-neck squamous cell carcinoma (HNSCC) Final analysis [Abstract] Int J Radiat Oncol Biol Phys 60 Suppl 2004 S190 S191
8. B. Cummings, B. O'Sullivan, T. Keane A prospective randomized trial of hyperfractionated vs. conventional once daily radiation for advanced squamous cell carcinoma of the larynx and pharynx - 5-year results [Abstract] Int J Radiat Oncol Biol Phys 48 Suppl 2000 151
9. J.C. Horiot, R. Le Fur, T. N'Guyen Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241
10. L.H. Pinto, P.C. Canary, C.M. Araujo Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 21 1991 557 562
11. H.R. Withers, J.M. Taylor, B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
12. K.K. Ang Concurrent radiation chemotherapy for locally advanced head and neck carcinoma Are we addressing burning subjects? J Clin Oncol 22 2004 4605 4607
13. A. Trotti, S.M. Bentzen The need for adverse effects reporting standards in oncology clinical trials J Clin Oncol 22 2004 19 22
14. J.P. Pignon, J. Bourhis, C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949 955
15. J. Bourhis, C. Amand, J.P. Pignon Update of MACH-NC (Meta-analysis of chemotherapy in head & neck cancer) database focused on concomitant chemoradiotherapy [Abstract] J Clin Oncol 23 Suppl 2004 488
16. T.G. Wendt, G.G. Grabenbauer, C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer A randomized multicenter study J Clin Oncol 16 1998 1318 1324
17. D.J. Adelstein, P. Lavertu, J.P. Saxton Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck Cancer 88 2000 876 883
18. B. Jeremic, B. Milicic, A. Dagovic Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck J Clin Oncol 22 2004 3540 3548
19. G. Calais, M. Alfonsi, E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
20. F. Denis, P. Garaud, E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
21. V. Budach, M. Stuschke, W. Budach Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer. Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial J Clin Oncol 23 2005 1125 1135
22. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
23. D.K. Kelleher, U. Mattheinsen, O. Thews Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats Cancer Res 56 1996 4728 4734
24. D.K. Kelleher, U. Matthiensen, O. Thews Tumor oxygenation in anemic rats Effects of erythropoietin treatment versus red blood cell transfusion Acta Oncol 34 1995 379 384
25. 2 histography in patients with advanced head and neck cancer Strahlenther Onkol 177 2001 462 468
26. D.M. Brizel, R.K. Dodge, R.W. Clough Oxygenation of head and neck cancer Changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 1999 113 117
27. A. Becker, P. Stadler, R.S. Lavey Severe anemia is associated with poor tumor oxygenation in head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466
28. M. Henke, R. Laszig, C. Rübe Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy Randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
29. G. Acs, P. Acs, S.M. Beckwith Erythropoietin and erythropoietin receptor expression in human cancer Cancer Res 61 2001 3561 3565